Physician
Hematology
Dr. Stefan O. Ciurea, MD
|
|
Give Review
Stefan O. Ciurea, MD works in the field of Hematology. He went to medical school at University of Illinois College of Medicine at Chicago. University of Illinois College of Medicine at Chicago is ranked 49 in research and 85 in primary care medicine Stefan Ciurea is a published MD. He published 62 publications, including: 'Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.
- Reply to: Use of Single-Antigen Flow Beads Assays to Assess Anti-HLA Donor-Specific Antibody Strength.
- Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
- Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation.
- Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning.
- Are changes in HLA Ags responsible for Leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
- Enforced fucosylation of cord blood hematopoietic Cells accelerates neutrophil and platelet engraftment after transplantation.
- Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hemato...
- Can a Female Donor for a Male Recipient Decrease Relapse Rate for Patients with AML Treated with Allogeneic Hematopoietic Stem Cell Transplantation?
- An update on allogeneic hematopoietic progenitor Cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors.
- BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic Leukemia/lymphoma: reduced myelosuppression and GVHD.
- "No donor"? Consider a haploidentical transplant.
- Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen-Matched Unre...
- Cytogenetics, Donor Type, and Use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation.
- The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
- Strategies in Haploidentical Stem Cell Transplantation in Adults.
- Allogeneic stem cell transplantation as initial salvage for patients with Acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.
- Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Inpatient Mortality and Survival in Patients Who Received Allogeneic Transplantation Admitted to...
- Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor Cell mobilization.
- Cytarabine, Ki-67, and SOX11 in patients with mantle cell Lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission.
- A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients w...
- Outcomes of adults with Acute lymphoblastic leukemia (ALL) following relapse post allogeneic hematopoietic stem cell transplantation (HSCT).
- Incidence and natural history of pure red Cell aplasia in major ABO-mismatched haematopoietic Cell transplantation.
- Cord-blood engraftment with ex vivo mesenchymal-Cell coculture.
- High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-Cell transplantation in patients with refractory lymphoid malignancies.
- Fifty Years of Melphalan Use in Hematopoietic Stem Cell Transplantation.
- Donor selection in T-Cell replete haploidentical hematopoietic stem-Cell transplantation: knowns, unknowns and controversies.
- Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplant.
- Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell...
- Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular Lymphoma: 12-year results.
- Humoral HLA sensitization matters in CBT outcome.
- Fludarabine, Melphalan, Thiotepa and ATG Conditioning for Unrelated Cord Blood Transplantation.
- Donor-specific anti-HLA antibodies and graft failure in matched unrelated donor hematopoietic stem Cell transplantation.
- Progress in Haploidentical Stem Cell Transplantation.
- Outcomes of Patients Treated and One Human Leukocyte Antigen-Mismatched Related Compared with Matched Unrelated Donors.
- Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement.
- Lymphocyte recovery predicts outcomes in cord blood and T Cell-depleted haploidentical stem Cell transplantation.
- Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared with One Human Le...
- Allogeneic stem Cell transplantation for myelofibrosis with leukemic transformation.
- High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-Cell transplantation.
- Aging, Acute myelogenous leukemia, and allogeneic transplantation: do they belong in the same sentence?
- Busulfan in hematopoietic stem Cell transplantation.
- Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis.
- Cytokines for the treatment of thrombocytopenia.
- Philadelphia chromosome-negative myeloproliferative Disorders: biology and treatment.
- Pulmonary extramedullary hematopoiesis in patients with myelofibrosis undergoing allogeneic stem Cell transplantation.
- Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem Cell transplantation.
- Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem Cell transplantation.
- Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin Lymphoma: pre...
- The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem Cell transplantation without the use of blood products.
- Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
- Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT.
- Dural venous sinus Thrombosis in a patient with sickle cell disease: case report and literature review.
- [Therapy of malignant liver tumors using microwave and radiofrequency ablation].
- [Current treatment of hepatoCellular carcinoma. Analysis of a series of 123 cases over a 5-year period].
- [Orthotopic liver transplantation in adult patients with cadaveric grafts. Experience of the Fundeni Center of General Surgery and Liver Transplantation].
- Liver hemangioma revisited: current surgical indications, technical aspects, results.
- [The value of resection in pancreatic cancer: the analysis of an experience of 180 patients in 10 years].
- Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with Polycythemia vera.
- [Neoadjuvant radiochemotherapy in the treatment of esophageal squamous carcinoma:Preliminary results in a series of 15 patients].
- Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Burkitt's Lymphoma
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
University of Illinois College of Medicine at Chicago -
University of Medicine and Pharmacy Pope Gregory
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1710149752 | |
| NPPES Provider LastName | CIUREA | |
| NPPES Provider FirstName | STEFAN | |
| NPPES Provider ZIPCode | 770304000 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology | |
| Total Claim Count | 397.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710149752 |
| Last Name Of The Provider | CIUREA |
| First Name Of The Provider | STEFAN |
| View All |
Similar Doctors
|
|
Dr. Jennifer Atlas, MD |
|
|
Dr. Uday R. Popat, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James T. Cao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natalia Golardi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret O. Uthman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miguel A. Escobar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chitra Balasundaram, MD |
|
|
Dr. Vahid Afsharkharghan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesus H. Hermosillo, MD |
|
|
Dr. Swaminathan P. Iyer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ronjay Rakkhit, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles E. Manner Jr., MD
This Doctor is OpenDoctor Recommended.
|